Technology | Treatment Planning | May 02, 2016

Latest version features up to four times faster calculation spped for reduced radiotherapy planning times

Elekta, ESTRO 35, Monaco treatment planning system, radiotherapy, version 5.11

May 2, 2016 — Elekta announced that Monaco version 5.11, the latest update to its treatment planning software, is available for clinical release.

Real-world testing has shown that Monaco version 5.11 provides significant performance speed enhancements over prior versions. Users can now attain calculation speeds up to four times faster than in previous versions of Monaco. With the Monte Carlo algorithm, users can achieve robust accuracy combined with speed and performance.

Fast plan calculation time is just one of the many characteristics in Monaco designed to improve overall efficiency. Monaco templates enable users to easily import and export treatment plans, facilitating sharing across departments and organizations. With the ability to create multiple prescription plans at one time, overall planning time is reduced. Additionally, improved data sharing creates additional opportunities to optimize individual treatment plans to meet the needs of each patient.

“The optimization speed enhancements in version 5.11, combined with previous innovations, such as template planning, provide substantial improvements in planning workflow efficiencies, while continuing to deliver highly accurate treatment plans using Monte Carlo dose calculations,” said Sotiri Stathakis, Ph.D., associate professor, radiation oncology and radiology at University of Texas Health Science Center in San Antonio, Texas. “We have been testing Monaco version 5.11 for several months and, so far, we have seen up to 3-4 times reduction in the optimization of VMAT [volumetric modulated arc therapy] plans equivalent to a 70 percent reduction in optimization times.”

Monaco was one of several innovations highlighted during the 2016 meeting of the European Society for Therapeutic Radiation & Oncology (ESTRO 35), April 29-May 3 in Turin, Italy.

For more information: www.elekta.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now